SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
| Recalling firm | Apollo Care, LLC |
|---|---|
| Reason | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material |
| Risk class | Class II (Class II · moderate) |
| Status | Ongoing |
| Report date | Aug 19, 2026 |
| Initiated | Jul 29, 2026 |
| Region | MO, United States |
| Distribution | Nationwide within the U.S |
| Quantity | 250 vials. |
| Code/Lot | Lot: AC-017272, Exp. 12/12/2026. |
| Type | Voluntary: Firm initiated |
| Recall number | D-0754-2026 |
Official source
U.S. FDA — Recalls, Market Withdrawals & Safety Alerts fda.gov ↗You can re-verify each item on the official FDA site using its recall number. (Recall number: D-0754-2026)
openFDA (U.S. Food & Drug Administration) — food/drug/device enforcement · CC0 1.0 (public domain)
Find out more
- Search this recall on FDA fda.gov ↗
- Search related news (Google News) news.google.com ↗
- Search this product (Google) google.com ↗
The links above open external searches by recall number / product name; the results are the responsibility of each site.
This page summarizes U.S. FDA data for general information and is not medical advice. Confirm details via official FDA announcements and the manufacturer.